Zhongshan Bailing Biotechnology Co., Ltd. deals in products.

The leading product is ursodeoxycholic acid, which occupies the third place in the global market share, and the packaging specification is 25 kg paper barrel. Its preparation product is one of the two basic drugs for hepatobiliary diseases in the first part of the National Essential Drugs Catalogue (2009 edition). It is also the only drug used in liver transplantation in the world to improve the survival rate of liver transplantation. It is the first choice for cholestatic liver diseases such as alcoholic and fatty liver diseases, viral hepatitis and drug-induced hepatitis, and it is the first choice for the treatment of cholesterol stones. The annual production capacity of ursodeoxycholic acid raw materials is 60 tons.